{"id":"W2012110426","doi":"10.1053/j.gastro.2012.09.031","title":"Challenges to the Design, Execution, and Analysis of Randomized Controlled Trials for Inflammatory Bowel Disease","year":2012,"lang":"en","type":"review","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; Robarts Clinical Trials; Western University","funders":"Janssen Pharmaceuticals; Genentech; Tillotts Pharma; Vifor Pharma; Ferring Pharmaceuticals; Zalicus; Optimer Pharmaceuticals; Otsuka America; UCB; Schering-Plough; Boehringer Ingelheim; Takeda Pharmaceutical Company; Novartis; Celgene; Novo Nordisk; Johnson and Johnson; Teva Pharmaceutical Industries; Gilead Sciences; Procter and Gamble; Roche; Orexigen Therapeutics; Merck; GlaxoSmithKline; Pfizer; Shire; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Dr. Falk Pharma; Abbott Laboratories","keywords":"Inflammatory bowel disease; Medicine; Randomized controlled trial; Disease; Intensive care medicine; Inflammatory Bowel Diseases; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009758768,0.0005285113,0.00695711,0.0004154022,0.00007492606,0.00001880147,0.000393025,0.0002900991,0.00001707274],"category_scores_gemma":[0.003904572,0.0003047002,0.003957965,0.00007181471,0.000253801,0.000004048277,0.0001853347,0.000105231,0.000003553038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001897623,"about_ca_system_score_gemma":0.0001578905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":6.58301e-7,"about_ca_topic_score_gemma":0.00002851361,"domain_scores_codex":[0.9904938,0.006285045,0.002025968,0.0005624213,0.0001611359,0.0004716154],"domain_scores_gemma":[0.9960588,0.001037556,0.001590724,0.0007830266,0.0002190876,0.0003107902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.7993275,0.0003485983,0.0007314049,0.01105305,0.1017459,0.0000248547,0.0002170315,0.0003733426,0.00004680143,0.0008115144,0.002122532,0.08319744],"study_design_scores_gemma":[0.2157752,0.0005981813,0.003740459,0.00102453,0.3109646,0.00001859636,0.0000460854,0.0002677392,0.000004351532,0.00008765725,0.4666861,0.0007865272],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006450558,0.9774915,0.01276609,0.0001756252,0.0002679242,0.008240479,0.000391592,0.0000104813,0.00001125591],"genre_scores_gemma":[0.001785393,0.9900928,0.0003038071,0.0002043721,0.0004333687,0.00655894,0.0005059916,0.00004948003,0.00006582926],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5835524,"threshold_uncertainty_score":0.9999405,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05940023155815793,"score_gpt":0.3238657225901835,"score_spread":0.2644654910320255,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}